vs
ASP Isotopes Inc.（ASPI）与基华物流（CEVA）财务数据对比。点击上方公司名可切换其他公司
基华物流的季度营收约是ASP Isotopes Inc.的1.6倍（$27.0M vs $16.7M），ASP Isotopes Inc.同比增速更快（1295.7% vs 11.5%）
ASP Isotopes Inc.是一家特种材料企业，专注于高纯度定制同位素的研发与生产，产品广泛应用于核医学、靶向抗癌治疗、清洁能源及工业研究等领域，客户覆盖北美、欧洲及亚太地区。
赛物流是一家全球物流与供应链企业，提供货运管理以及合约物流服务，2019年被达飞海运集团收购。收购完成后，达飞集团陆续将英格迈微商务生命周期服务、GEFCO等多家物流运输企业并入赛物流，助力其业务发展与规模扩张。
ASPI vs CEVA — 直观对比
营收规模更大
CEVA
是对方的1.6倍
$16.7M
营收增速更快
ASPI
高出1284.2%
11.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $16.7M | $27.0M |
| 净利润 | — | — |
| 毛利率 | 12.5% | 86.2% |
| 营业利润率 | — | -5.0% |
| 净利率 | — | — |
| 营收同比 | 1295.7% | 11.5% |
| 净利润同比 | -586.8% | — |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPICEVA
| Q1 26 | — | $27.0M | ||
| Q4 25 | $16.7M | $31.3M | ||
| Q3 25 | $4.9M | $28.4M | ||
| Q2 25 | — | $25.7M | ||
| Q1 25 | — | $24.2M | ||
| Q4 24 | — | $29.2M | ||
| Q3 24 | — | $27.2M | ||
| Q2 24 | — | $28.4M |
净利润ASPICEVA
| Q1 26 | — | — | ||
| Q4 25 | — | $-1.1M | ||
| Q3 25 | $-12.9M | $-2.5M | ||
| Q2 25 | — | $-3.7M | ||
| Q1 25 | — | $-3.3M | ||
| Q4 24 | — | $-1.7M | ||
| Q3 24 | — | $-1.3M | ||
| Q2 24 | — | $-291.0K |
毛利率ASPICEVA
| Q1 26 | — | 86.2% | ||
| Q4 25 | 12.5% | 88.1% | ||
| Q3 25 | 8.7% | 88.0% | ||
| Q2 25 | — | 86.2% | ||
| Q1 25 | — | 85.6% | ||
| Q4 24 | — | 88.5% | ||
| Q3 24 | — | 85.4% | ||
| Q2 24 | — | 89.7% |
营业利润率ASPICEVA
| Q1 26 | — | -5.0% | ||
| Q4 25 | — | -1.3% | ||
| Q3 25 | -306.1% | -7.3% | ||
| Q2 25 | — | -17.5% | ||
| Q1 25 | — | -18.1% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | -9.6% | ||
| Q2 24 | — | -0.1% |
净利率ASPICEVA
| Q1 26 | — | — | ||
| Q4 25 | — | -3.5% | ||
| Q3 25 | -263.7% | -8.8% | ||
| Q2 25 | — | -14.4% | ||
| Q1 25 | — | -13.7% | ||
| Q4 24 | — | -5.9% | ||
| Q3 24 | — | -4.8% | ||
| Q2 24 | — | -1.0% |
每股收益（稀释后）ASPICEVA
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $-0.15 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $333.3M | $21.4M |
| 总债务越低越好 | $14.4M | — |
| 股东权益账面价值 | $204.2M | $338.2M |
| 总资产 | $498.0M | $388.2M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资ASPICEVA
| Q1 26 | — | $21.4M | ||
| Q4 25 | $333.3M | $40.6M | ||
| Q3 25 | $113.9M | $17.3M | ||
| Q2 25 | — | $29.1M | ||
| Q1 25 | — | $18.8M | ||
| Q4 24 | — | $18.8M | ||
| Q3 24 | — | $13.2M | ||
| Q2 24 | — | $25.0M |
总债务ASPICEVA
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | — | ||
| Q3 25 | $13.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ASPICEVA
| Q1 26 | — | $338.2M | ||
| Q4 25 | $204.2M | $336.5M | ||
| Q3 25 | $74.1M | $268.7M | ||
| Q2 25 | — | $265.9M | ||
| Q1 25 | — | $269.1M | ||
| Q4 24 | — | $266.6M | ||
| Q3 24 | — | $265.8M | ||
| Q2 24 | — | $263.8M |
总资产ASPICEVA
| Q1 26 | — | $388.2M | ||
| Q4 25 | $498.0M | $388.3M | ||
| Q3 25 | $225.9M | $306.0M | ||
| Q2 25 | — | $302.8M | ||
| Q1 25 | — | $310.0M | ||
| Q4 24 | — | $308.9M | ||
| Q3 24 | — | $304.9M | ||
| Q2 24 | — | $300.4M |
负债/权益比ASPICEVA
| Q1 26 | — | — | ||
| Q4 25 | 0.07× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.8M | — |
| 自由现金流经营现金流 - 资本支出 | $-47.4M | — |
| 自由现金流率自由现金流/营收 | -284.7% | — |
| 资本支出强度资本支出/营收 | 57.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASPICEVA
| Q1 26 | — | — | ||
| Q4 25 | $-37.8M | $8.7M | ||
| Q3 25 | $-8.9M | $-5.9M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $-7.4M | ||
| Q4 24 | — | $8.0M | ||
| Q3 24 | — | $399.0K | ||
| Q2 24 | — | $2.4M |
自由现金流ASPICEVA
| Q1 26 | — | — | ||
| Q4 25 | $-47.4M | $7.2M | ||
| Q3 25 | $-12.0M | $-6.3M | ||
| Q2 25 | — | $492.0K | ||
| Q1 25 | — | $-7.7M | ||
| Q4 24 | — | $7.0M | ||
| Q3 24 | — | $-15.0K | ||
| Q2 24 | — | $1.8M |
自由现金流率ASPICEVA
| Q1 26 | — | — | ||
| Q4 25 | -284.7% | 23.1% | ||
| Q3 25 | -245.5% | -22.1% | ||
| Q2 25 | — | 1.9% | ||
| Q1 25 | — | -31.8% | ||
| Q4 24 | — | 24.0% | ||
| Q3 24 | — | -0.1% | ||
| Q2 24 | — | 6.2% |
资本支出强度ASPICEVA
| Q1 26 | — | — | ||
| Q4 25 | 57.9% | 4.8% | ||
| Q3 25 | 64.4% | 1.5% | ||
| Q2 25 | — | 2.7% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | — | 3.5% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 2.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASPI
暂无分部数据
CEVA
| Licensing and related revenues | $17.8M | 66% |
| Royalties | $9.2M | 34% |
